Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Insurance Stocks Moving In Friday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

Why This Analyst Downgraded Fortinet And CommScope

While Fortinet Inc.’s (NASDAQ: FTNT) stock already prices in the company’s strong results, CommScope Holding Company Inc (NASDAQ: COMM) has limited catalysts to drive growth in the near term, according to Bo

Benzinga

Analysts Cut LiqTech's Price Target After FY21 Results

LiqTech International Inc (NASDAQ:LIQT) price target has been lowered to $9 from $14 by Lake Street analyst Robert Brown. The analyst maintained his Buy rating on LIQT shares. Brown revised his estimates lower as the macro environment delays orders. Meanwhile, he notes business case for marine scrubbers has improved. Related: Why Are LiqTech Shares…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Tesla Stock Looks Set To Soar And How To Trade This Key Pattern

Tesla, Inc (NASDAQ: TSLA) was trading mostly flat on Friday in a tight range between about $1,001 and $1,017 after trading in a fairly tight range on Thursday

Benzinga

Why PayPal Looks Set To Explode Higher (And How To Trade This Key Pattern)

PayPal Holdings, Inc (NASDAQ: PYPL) was trading down about 3% on Friday as the stock continued to trade sideways after shooting up about 26% between March 14 and March 18.

Benzinga

Mid-Day Market Update: Nasdaq Down 1%; Icosavax Shares Plummet

U.S. stocks pared gains midway through trading, with the Nasdaq Composite dropping 1% on Friday.

Benzinga

What 12 Analyst Ratings Have To Say About Roku

Over the past 3 months, 12 analysts have published their opinion on Roku (NASDAQ:ROKU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Like It Hot? Netflix Gets Rare NC-17 Rating On Marilyn Monroe Biopic

Netflix (NASDAQ: NFLX) has received a rare NC-17 rating from the Motion Picture Association (MPA) for its new biopic on Marilyn Monroe.

Benzinga

Stocks That Hit 52-Week Lows On Friday

On Friday, 166 companies set new 52-week lows.

Benzinga

What 5 Analyst Ratings Have To Say About Ansys

Over the past 3 months, 5 analysts have published their opinion on Ansys (NASDAQ:ANSS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

36 Stocks Moving In Friday's Mid-Day Session

Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70.

Benzinga

Here's Why Affirm, Enphase Energy And Zoom Shares Are Falling

Shares of several companies in the broader technology sector, Affirm Holdings Inc (NASDAQ: AFRM), Enphase Energy Inc (NASDAQ: ENPH) and Zoom Video Communications Inc (NASDAQ:

Benzinga

COCP: Cocrystal Pharma releases 2021 fiscal year results and provides an update on the current pipeline programs

By Thomas Kerr, CFA NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT

Benzinga

Here's Why Li Auto And XPeng Shares Are Falling Following Nio's Earnings Report

Li Auto Inc (NASDAQ: LI) and XPeng Inc - ADR (NYSE: XPEV) shares are trading lower after peer company Nio Inc - ADR (NYSE: NIO) repo

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Earnings Preview: Advent Technologies Holdings, Inc. - Class A Common Stock

Advent Technologies Holdings, Inc. - Class A Common Stock (NASDAQ:ADN) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement.

Benzinga

Iterum Therapeutics Earnings Preview

Iterum Therapeutics (NASDAQ:ITRM) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Iterum Therapeutics will report an earnings per share (EPS) of $-0.04.

Benzinga

What Are Whales Doing With Rivian Automotive

Someone with a lot of money to spend has taken a bearish stance on Rivian Automotive (NASDAQ:RIVN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Earnings Outlook For CASI Pharmaceuticals

CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that CASI Pharmaceuticals will report an earnings per share (EPS) of $-0.06.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Earnings Preview: Viomi Technology Co

Viomi Technology Co (NASDAQ:VIOT) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Viomi Technology Co will report an earnings per share (EPS) of $0.02.

Benzinga

Greenland Technologies Earnings Preview

Greenland Technologies (NASDAQ:GTEC) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Greenland Technologies will report an earnings per share (EPS) of $0.11.

Benzinga

Cyclacel Pharmaceuticals's Earnings: A Preview

Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Cyclacel Pharmaceuticals will report an earnings per share (EPS) of $-0.65.

Benzinga

Earnings Preview: Progenity

Progenity (NASDAQ:PROG) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Progenity will report an earnings per share (EPS) of $-0.16.

Benzinga

DXP Enterprises Clocks 26% Sales Growth In Q4, Changes Auditor

DXP Enterprises Inc (NASDAQ:DXPE) reported fourth-quarter sales growth of 26% year-over-year to $293.1 million. Sales by segments: Service Centers $207.96 million (+28.9% Y/Y), Innovative Pumping Solutions $43.18 million (+21.2% Y/Y), and Supply Chain Services $42.02 million (+17.4% Y/Y). EPS was $0.05 versus $(0.18) in 4Q20. The gross margin expanded by 200 bps…

Benzinga

Preview: Marrone Bio Innovations's Earnings

Marrone Bio Innovations (NASDAQ:MBII) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Marrone Bio Innovations will report an earnings per share (EPS) of $-0.03.

Benzinga

What 4 Analyst Ratings Have To Say About Viper Energy Partners

Within the last quarter, Viper Energy Partners (NASDAQ:VNOM) has observed the following analyst ratings:

1 … 778 779 780 781

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.